Barbara Kosacz, COO & General Counsel at Kronos Bio, Inc. (KRON), bought 5,250 shares at $19.00 ($100K) on 2020-10-14, disclosed to the SEC on 2020-10-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.